Luke Sergott
Stock Analyst at Barclays
(4.07)
# 1,795
Out of 4,572 analysts
735
Total ratings
46.2%
Success rate
5.5%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintained: Buy | $230 → $250 | $227.86 | +9.72% | 19 | Jul 24, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $625 → $650 | $568.26 | +14.38% | 46 | Jul 24, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | $400 | $328.20 | +21.88% | 11 | Jul 24, 2026 | |
| RGEN Repligen | Maintained: Buy | $160 | $131.96 | +21.25% | 11 | Jul 23, 2026 | |
| MEDP Medpace Holdings | Maintained: Hold | $450 | $601.38 | -25.17% | 10 | Jul 23, 2026 | |
| DHR Danaher | Maintained: Buy | $230 | $191.50 | +20.10% | 46 | Jul 21, 2026 | |
| QGEN Qiagen | Maintained: Hold | $38 | $41.37 | -8.15% | 17 | Jul 8, 2026 | |
| A Agilent Technologies | Rated: Buy | $145 → $150 | $138.57 | +8.25% | 33 | Jun 24, 2026 | |
| BRKR Bruker | Rated: Buy | $53 → $60 | $60.45 | -0.74% | 18 | Jun 24, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Hold | $150 → $175 | $165.76 | +5.57% | 41 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $122 → $145 | $194.09 | -25.29% | 49 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $105 | $110.47 | -4.95% | 33 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $425 | $374.68 | +13.43% | 34 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $208.05 | +0.94% | 48 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $280 → $260 | $261.99 | -0.76% | 14 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $120 → $150 | $147.33 | +1.81% | 18 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $95 | $90.27 | +5.24% | 40 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $7 → $8 | $11.44 | -30.07% | 44 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $40 | $46.27 | -13.55% | 34 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $19 | $17.35 | +9.51% | 42 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $16 → $18 | $19.52 | -7.79% | 20 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $220 | $226.58 | -2.90% | 19 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $6.5 | $7.51 | -13.45% | 35 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $1 → $1.5 | $1.36 | +10.29% | 26 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,500 | $1,327.18 | +13.02% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $290 | $296.77 | -2.28% | 15 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $42 | $6.34 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 | $288.30 | n/a | 1 | Jan 18, 2023 |
Quest Diagnostics
Jul 24, 2026
Maintained: Buy
Price Target: $230 → $250
Current: $227.86
Upside: +9.72%
Thermo Fisher Scientific
Jul 24, 2026
Maintained: Buy
Price Target: $625 → $650
Current: $568.26
Upside: +14.38%
West Pharmaceutical Services
Jul 24, 2026
Maintained: Buy
Price Target: $400
Current: $328.20
Upside: +21.88%
Repligen
Jul 23, 2026
Maintained: Buy
Price Target: $160
Current: $131.96
Upside: +21.25%
Medpace Holdings
Jul 23, 2026
Maintained: Hold
Price Target: $450
Current: $601.38
Upside: -25.17%
Danaher
Jul 21, 2026
Maintained: Buy
Price Target: $230
Current: $191.50
Upside: +20.10%
Qiagen
Jul 8, 2026
Maintained: Hold
Price Target: $38
Current: $41.37
Upside: -8.15%
Agilent Technologies
Jun 24, 2026
Rated: Buy
Price Target: $145 → $150
Current: $138.57
Upside: +8.25%
Bruker
Jun 24, 2026
Rated: Buy
Price Target: $53 → $60
Current: $60.45
Upside: -0.74%
ICON Public Limited Company
Jun 24, 2026
Maintained: Hold
Price Target: $150 → $175
Current: $165.76
Upside: +5.57%
Jun 24, 2026
Rated: Sell
Price Target: $122 → $145
Current: $194.09
Upside: -25.29%
Jun 24, 2026
Maintained: Hold
Price Target: $105
Current: $110.47
Upside: -4.95%
Jun 24, 2026
Maintained: Buy
Price Target: $425
Current: $374.68
Upside: +13.43%
Jun 24, 2026
Maintained: Buy
Price Target: $210
Current: $208.05
Upside: +0.94%
Jun 24, 2026
Rated: Buy
Price Target: $280 → $260
Current: $261.99
Upside: -0.76%
Jun 24, 2026
Rated: Buy
Price Target: $120 → $150
Current: $147.33
Upside: +1.81%
Jun 24, 2026
Rated: Buy
Price Target: $65 → $95
Current: $90.27
Upside: +5.24%
Jun 24, 2026
Rated: Sell
Price Target: $7 → $8
Current: $11.44
Upside: -30.07%
Jun 24, 2026
Rated: Buy
Price Target: $30 → $40
Current: $46.27
Upside: -13.55%
Jun 24, 2026
Rated: Buy
Price Target: $18 → $19
Current: $17.35
Upside: +9.51%
Jun 24, 2026
Rated: Hold
Price Target: $16 → $18
Current: $19.52
Upside: -7.79%
Jun 8, 2026
Maintained: Buy
Price Target: $220
Current: $226.58
Upside: -2.90%
May 12, 2026
Rated: Hold
Price Target: $8 → $6.5
Current: $7.51
Upside: -13.45%
May 11, 2026
Rated: Sell
Price Target: $1 → $1.5
Current: $1.36
Upside: +10.29%
May 8, 2026
Maintained: Buy
Price Target: $1,500
Current: $1,327.18
Upside: +13.02%
May 1, 2026
Rated: Hold
Price Target: $290
Current: $296.77
Upside: -2.28%
Jun 12, 2023
Maintained: Hold
Price Target: $35 → $42
Current: $6.34
Upside: n/a
Jan 18, 2023
Rated: Buy
Price Target: $200
Current: $288.30
Upside: n/a